Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketty Peris

Showing results (421-430 of 533) with videos related to

Pageof 54
Sort By:
Acta Dermato-Venereologica|October 3, 2025
Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special PopulationsNiccolo Gori, Alvise Sernicola, Elena Ippoliti, et al.
Italian Journal of Dermatology and Venereology|June 6, 2023
Line-field confocal optical coherence tomography in melanocytic and non-melanocytic skin tumorsMariano Suppa, Gerardo Palmisano, Linda Tognetti, et al.
Journal of the American Academy of Dermatology|December 6, 2020
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) groupVasiliki Nikolaou, Vincent Sibaud, Davide Fattore, et al.
Cancers|June 13, 2025
Clinical and Histological Predictors of Advanced Basal Cell Carcinoma Recurrence After Complete Response to Hedgehog Pathway Inhibitors: A Retrospective Multicenter Observational StudyMaria Mannino, Massimiliano Scalvenzi, Alessandro Di Stefani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 29, 2024
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case seriesNiccolò Gori, Elena Ippoliti, Silvia Mariel Ferrucci, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2018
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortiumAlexander J Stratigos, Maria Concetta Fargnoli, Arcangela De Nicolo, et al.
The Oncologist|December 21, 2023
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Therapeutic Advances in Chronic Disease|June 18, 2019
PsA-Disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients: an Italian derma-rheuma multicentre studyMaria Sole Chimenti, Maria Esposito, Dario Graceffa, et al.
The Journal of Dermatological Treatment|November 3, 2025
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictorsNiccolò Gori, Lucia Di Nardo, Elena Ippoliti, et al.
Dermatology Practical & Conceptual|March 21, 2025
Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in ItalyFederico Pirro, Giacomo Caldarola, Nicoletta Bernardini, et al.
Pageof 54

Showing results (421-430 of 533) with videos related to

Sort By:
Pageof 54
Acta Dermato-Venereologica|October 3, 2025
Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special PopulationsNiccolo Gori, Alvise Sernicola, Elena Ippoliti, et al.
Italian Journal of Dermatology and Venereology|June 6, 2023
Line-field confocal optical coherence tomography in melanocytic and non-melanocytic skin tumorsMariano Suppa, Gerardo Palmisano, Linda Tognetti, et al.
Journal of the American Academy of Dermatology|December 6, 2020
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) groupVasiliki Nikolaou, Vincent Sibaud, Davide Fattore, et al.
Cancers|June 13, 2025
Clinical and Histological Predictors of Advanced Basal Cell Carcinoma Recurrence After Complete Response to Hedgehog Pathway Inhibitors: A Retrospective Multicenter Observational StudyMaria Mannino, Massimiliano Scalvenzi, Alessandro Di Stefani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 29, 2024
Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case seriesNiccolò Gori, Elena Ippoliti, Silvia Mariel Ferrucci, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 12, 2018
MelaNostrum: a consensus questionnaire of standardized epidemiologic and clinical variables for melanoma risk assessment by the melanostrum consortiumAlexander J Stratigos, Maria Concetta Fargnoli, Arcangela De Nicolo, et al.
The Oncologist|December 21, 2023
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Therapeutic Advances in Chronic Disease|June 18, 2019
PsA-Disk, a novel visual instrument to evaluate psoriatic arthritis in psoriatic patients: an Italian derma-rheuma multicentre studyMaria Sole Chimenti, Maria Esposito, Dario Graceffa, et al.
The Journal of Dermatological Treatment|November 3, 2025
Baricitinib for adult atopic dermatitis: real-world effectiveness, safety, and response predictorsNiccolò Gori, Lucia Di Nardo, Elena Ippoliti, et al.
Dermatology Practical & Conceptual|March 21, 2025
Risankizumab Versus Secukinumab: A Real-World Efficacy and Cost per Responder Comparison in Patients With Psoriasis in ItalyFederico Pirro, Giacomo Caldarola, Nicoletta Bernardini, et al.
Pageof 54